RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (OTCPK: LBTN) today announced that its Neural Network Classification of breast cancer with blind temperature screening is no longer a myth but a fact.
RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (OTCPK: LBTN) today announced that its Neural Network Classification of breast cancer with blind temperature screening is no longer a myth but a fact.
